{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:37:35Z","timestamp":1791509855637,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/ftd.0b013e31827a1aad","type":"journal-article","created":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T10:45:32Z","timestamp":1357987532000},"page":"84-91","source":"Crossref","is-referenced-by-count":29,"title":["The Relation Between Dosage, Serum Concentrations, and Clinical Outcome in Children and Adolescents Treated With Sertraline"],"prefix":"10.1097","volume":"35","author":[{"given":"Regina","family":"Taurines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wewetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pfuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mehler-Wex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00004583-200110000-00011","article-title":". Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.","volume":"40","author":"Cook","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R2-9-20210129","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/01.chi.0000177324.40005.6f","article-title":". Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder.","volume":"44","author":"Asbahr","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R4-9-20210129","first-page":"129","article-title":"Drug concentration monitoring with tolerability and efficacy assessments during open-label, long-term sertraline treatment of children and adolescents.","volume":"117-","author":"Alderman","year":"16","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-199905000-00018","article-title":". Multicenter open-label sertraline study in adolescent outpatients with major depression.","volume":"38","author":"Ambrosini","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.chi.0000233157.21925.71","article-title":". A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression.","volume":"45","author":"Melvin","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R7-9-20210129","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","article-title":"Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.","volume":"158","author":"Rynn","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R8-9-20210129","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","article-title":". Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.","volume":"290","author":"Wagner","year":"2003","journal-title":"JAMA"},{"key":"R9-9-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1192\/bjp.bp.106.031088","article-title":". Efficacy of antidepressants in juvenile depression: meta-analysis.","volume":"193","author":"Tsapakis","year":"2008","journal-title":"Br J Psychiatry"},{"key":"R10-9-20210129","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":". Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.","volume":"359","author":"Walkup","year":"2008","journal-title":"N Engl J Med"},{"key":"R11-9-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yebeh.2007.01.004","article-title":"Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression.","volume":"10","author":"Thome-Souza","year":"2007","journal-title":"Epilepsy Behav"},{"key":"R12-9-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/cap.1999.9.293","article-title":"Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial.","volume":"9","author":"Carlson","year":"1999","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R13-9-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/cap.1997.7.9","article-title":". Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder.","volume":"7","author":"Steingard","year":"1997","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00004714-199802000-00010","article-title":". Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation.","volume":"18","author":"McDougle","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R15-9-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JCP.0b013e318205e66d","article-title":". Antidepressant drugs in children and adolescents: analytical and demographic data in a naturalistic, clinical study.","volume":"31","author":"Cherma","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":". AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011.","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R17-9-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007691-200008000-00014","article-title":"Therapeutic drug monitoring of sertraline: Variability factors as displayed in a clinical setting.","volume":"22","author":"Lundmark","year":"2000","journal-title":"Ther Drug Monit"},{"issue":"suppl 1","key":"R18-9-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199700321-00004","article-title":"Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.","volume":"32","author":"Ronfeld","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"R19-9-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/cap.2006.16.159","article-title":"Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents.","volume":"16","author":"Safer","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R20-9-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-972573","article-title":". Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.","volume":"40","author":"Gerlach","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"R21-9-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1753-2000-3-14","article-title":". Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy.","volume":"3","author":"Mehler-Wex","year":"2009","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"R22-9-20210129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0031-1286291","article-title":"Therapeutic drug monitoring in child and adolescent psychiatry.","volume":"44","author":"Egberts","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R23-9-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-0029-1239540","article-title":". Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.","volume":"43","author":"Klampfl","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"R24-9-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2004-832687","article-title":". The AGNP-TDM expert group consensus guidelines: Therapeutic drug monitoring in psychiatry.","volume":"37","author":"Baumann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"R26-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":". A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R27-9-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","article-title":". Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database.","volume":"31","author":"Reis","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R28-9-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5414\/CPP40485","article-title":"Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.","volume":"40","author":"Kanamori","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R30-9-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors.","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"R31-9-20210129","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","article-title":". Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an 11CDASB positron emission tomography study.","volume":"161","author":"Meyer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R32-9-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1024\/1422-4917.34.1.5","article-title":". Therapeutisches Drug-Monitoring in der Kinder- und Jugendpsychiatrie-Grundlagen und praktische Empfehlungen.","volume":"34","author":"Gerlach","year":"2006","journal-title":"Z Kinder Jugendpsychiatr Psychother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31827a1aad","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:19Z","timestamp":1620952819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201302000-00009"}},"subtitle":["A Naturalistic Study"],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31827a1aad","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}